Influence of adrenal glands on the modulation of prolactin gene expression by the endogenous benzodiazepine ligand octadecaneuropeptide in the male rat pituitary gland

Journal of Neuroendocrinology

Volumn 10, Issue 3, 1998, Pages 193-198

  Wang, Hongbo ^a   Li, Songyun ^a   Givalois, Laurent ^a   Pelletier, Georges ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

Adrenal glands; GABA(A) receptors; Glucocorticoids; Octadecaneuropeptide; Pituitary prolactin

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; DEXAMETHASONE; MESSENGER RNA; NEUROPEPTIDE; OCTADECANEUROPEPTIDE; PROLACTIN;

ADRENAL GLAND; ADRENALECTOMY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CASTRATION; CONTROLLED STUDY; GENE EXPRESSION; HYPOPHYSIS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ADRENAL GLANDS; ADRENALECTOMY; ANIMALS; DEXAMETHASONE; DIAZEPAM BINDING INHIBITOR; GENE EXPRESSION REGULATION; GLUCOCORTICOIDS; INJECTIONS, INTRAVENTRICULAR; LIGANDS; MALE; NEUROPEPTIDES; ORCHIECTOMY; PEPTIDE FRAGMENTS; PITUITARY GLAND; PROLACTIN; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GABA; RNA, MESSENGER; TISSUE DISTRIBUTION;

EID: 0031888678     PISSN: 09538194     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2826.1998.00189.x     Document Type: Article

References (32)

1. Ben-Jonathan N, Arbogast LA, Hyde JF. Neuroendocrine regulation of prolactin release. Prog Neurobiol 1989; 33: 339-447.
2. De Plazas S, f. Becu D, De Novara AM, Libertun C. Gammaaminobutyric acid receptors in anterior pituitary and brain areas after median eminence lesions. Endocrinology 1982; 111: 1974-1978.
3. Anderson RA, Mitchell R. GABAA receptors have a biphasic effect on prolactin release in vitro from anterior pituitary of the rat. J Physiol 1984; 353: 100P.
4. Locatelli V, Cocchi D, Frigerio D, Betti C, Krogsgaard-Larsen R, Pacagni P, Muller EE. Dual gamma-aminobutyric acid control of prolactin secretion in the rat. Endocrinology 1979; 105: 778-785.
5. Fuchs E, Mansky T, Stock KW, Vijayan E, Wuttke W. Involvement of catecholamines and glutamate in GABAergic mechanism regulatory to luteinizing hormone and prolactin secretion. Neuroendocrinology 1984; 38: 484-489.
6. Casanueva F, Apud J, Locatelli V, Martinez-Campos A, Civati C, Racagni G, Cocchi D, Müller EE. Mechanisms subserving the stimulatory and inhibitory components of y-aminobutyric acid-ergic control of prolacting secretion in the rat. Endocrinology 1981; 109: 567-572.
7. Sieghart W. GABAA receptors: ligand-gated, Cl-ion channels modulated by multiple drug-binding sites. Trends Pharmacol Sci 1992; 13: 446-450.
8. Squires RF, Braestrup C. Benzodiazepine in rat brain. Nature 1977; 266: 732-734.
9. Guidotti A, Forchetti CM, Corda MG, Kondel D, Bennett CD, Costa E. Isolation, characterization and purification to homogeneity of an endogenous polypeptide with agonistic action on benzodiazepine receptors. Proc Natl Acad Sci USA 1983; 80: 3531-3535.
10. Ferrero P, Santi MR, Conti-Tronconi B, Costa E, Guidotti A. Study of an octadecaneuropeptide derived from diazepam binding inhibitor (DBI): biological activity and presence in rat brain. Proc Natl Acad Sci USA 1986; 83: 827 831.
11. Gray PW, Glaister D, Sceburg PH, Guidotti A, Costa E. Cloning and expression of a cDNA for human diazepam binding inhibitor, a natural ligand of an allosteric regulatory site of the y-aminobutyric acid type A receptor. Proc Natl Acad Sci USA 1986; 80: 7547 7551.
12. Goth MI, Lyons CE, Canny BJ, Thorner MO. Pituitary adenylate cyclase activating polypeptide, growth hormone (GH)-releasing peptide and GH-releasing hormone stimulate GH release through distinct pituitary receptors. Endocrinology 1992; 130: 939-943.
13. Guidotti A, Berkovich A, Muhkin A, Costa E. Diazepam-binding inhibitors: response to Knudsen and Nielsen. Biochem J 1990; 265: 928-930.
14. Li S, Pelletier G. Inhibitory effect of the endogenous benzodiazepine receptor ligand, octadecaneuropeptide (ODN), on gonadotropinreleasing hormone gene expression in the male rat brain. Neuroreport 1995; 6: 1354-1356.
15. Li S, Pelletier G. Further studies on the mechanism of action of the endogenous benzodiazepine ligand octodecaneuropeptide (ODN) on gonadotropin-releasing hormone gene expression in rat brain. Neuroendocrinology 1996; 64: 79-84.
16. Li S, Givalois L, Pelletier G. Role of adrenal and gonadal steroids in the response of GnRH gene expression to the endogenous benzodiazepine ligand octadecaneuropeptide in the male rat. Neuropeptides, 1997; 31: 463-468.
17. Caron RW, Salicioni AM, Peis RP. Mifrepristone treatment demonstrates the participation of adrenal glucocorticoids in the regulation of oestrogeninduced prolactin secretion in ovariectomized rats. J Steroid Biochem Mol Bioi 1994; 48: 385-391.
18. Dinan TG, Scott LV. The influence of cortisol on spontaneous and 5-HT stimulated prolactin release in man. J Basic Clin Physiol Pharmacol 1996; 7: 45 51.
19. Tong Y, Simard J, Labrie C, Zhao HF, Labrie F, Pelletier G. Inhibitory effect of androgen on estrogen-induced prolactin messenger ribonucleic acid accumulation in the male rat anterior pituitary gland. Endocrinology 1989; 125: 1821-1828.
20. Tong Y, Zhao HF, Simard J, Labrie F, Pelletier G. Electron microscopic autoradiographic localization of prolactin mRNA in rat pituitary. J Histochem Cytochem 1989; 37: 567-571.
21. Garcia De Yebenes E, Li S, Pelletier G. Regulation of proopiomelanocortin gene expression by endogenous ligands of the GABAA receptor complex as evaluated by in situ hybridization in the rat pars intermedia. Mol Brain Res 1997; 750: 277-284.
22. Fan J-PD. Angiosuppressive therapy for cancer. Trends Pharmacol Sci 1994; 15: 33 36.
23. Grandison L, Guidotti A. y-Aminobutyric acid receptor function in rat anterior pituitary: evidence for control of prolactin release. Endocrinology 1979; 105: 754-759.
24. Kimura F, Jinnai K, Funabashi T. A GABAb-receptor mechanism is involved in the prolactin release in both male and female rats. Neuroscience 1993; 155: 183-186.
25. Lux-Lanthos V, Rey E, Libertun C. Activation of GABA B receptors in the anterior pituitary inhibits prolactin and luteinizing hormone secretion. Neuroendocrinology 1992; 56: 687-693.
26. Tappaz ML, Bosler O, Taut L, Berod A. Glutamate-decarboxylase-immunoreactive boutons in synaptic contacts with hypothalamic dopaminergic cells: alight and electron microscopy study combining immunocytochemistry and radioautography. Neuroscience 1985; 16: 111 118.
27. Tonon MC, Désy L, Nicolas P, Vaudry H, Pelletier G. Immunocytochemical localization of the endogenous benzodiazepine ligand octadecaneuropeptide (ODN) in the rat brain. Neuropeptides 1990; 15: 17-24.
28. Lupien S, Richter R, Risch SC, Gillin JC, Haryer RL. Time course of the corticosteroid-dopaminergic interaction during metyrapone and dexamethosone administration. Psychiatry Res 1995; 58: 23 29.
29. Tong Y, Couet J, Simard J, Pelletier G. Glucocorticoid regulation of proopiomelanocortin (POMC) mRNA levels in rat arcuate nucleus. Moll Cell Neuroscience 1990; 1: 78 83.
30. Tong Y, Veilleux R, Pelletier G. Regulation of prolactin messenger ribonucleic acid levels by estradiol and dihydrotestosterone as evaluated by in situ hybridization performed on implanted pituitary glands and anterior pituitary cells in culture in the male rat. J Neuroendocrinol 1989; 4: 359-364.
31. Kramer CY. Extension of multiple range tests to group means with unique numbers of replications. Biometrics 1956; 12: 307.
32. Maurer RA. Estradiol regulate the transcription of the prolactin gene. J Biol Chem 1982; 257: 2133 2144.